Prelude Capital Management
BOLD icon

Prelude Capital Management’s Boundless Bio BOLD Stock Holding History

Prelude Capital Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210K Buy
+83,998
New +$129K 0.02% 965
2025
Q2 		– Sell
-16,624
Closed -$25.1K – 1441
2025
Q1 		$25.1K Hold
16,624
– – ﹤0.01% 1125
2024
Q4 		$48.2K Buy
16,624
+5,600
+51% +$16.3K ﹤0.01% 1148
2024
Q3 		$38.3K Buy
+11,024
New +$40K ﹤0.01% 1224

Other funds holding BOLD

Arch Venture Management
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Tang Capital Management
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ADAR1 Capital Management
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Cormorant Asset Management
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Prelude Capital Management's BOLD Position: Q2 2026 in Review

Prelude Capital Management opened a new position in Boundless Bio (BOLD) in Q2 2026: 83,998 shares worth $210K. The stake represents 0.02% of the portfolio and ranks #965 among its holdings. This is a return to the name: Prelude Capital Management previously reported a position in BOLD as recently as Q1 2025.

Prelude Capital Management first reported a position in BOLD in Q3 2024 and has held it in 4 quarters since. 40 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

  • Prelude Capital Management held 83,998 shares of Boundless Bio worth $210K as of Q2 2026.
  • Boundless Bio was a new Prelude Capital Management position in Q2 2026.
  • Boundless Bio made up 0.02% of Prelude Capital Management's portfolio in Q2 2026, its #965 holding.
  • Prelude Capital Management first reported a position in Boundless Bio in Q3 2024 and has held it in 4 quarters since.
  • 40 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.